CTT Pharmaceutical CTTH Stock
CTT Pharmaceutical Price Chart
CTT Pharmaceutical CTTH Financial and Trading Overview
| CTT Pharmaceutical stock price | 0.07 USD |
| Previous Close | 0.07 USD |
| Open | 0.08 USD |
| Bid | 0.07 USD x 1000000 |
| Ask | 0.08 USD x 4250000 |
| Day's Range | 0.08 - 0.08 USD |
| 52 Week Range | 0.02 - 0.1 USD |
| Volume | 860 USD |
| Avg. Volume | 26.57K USD |
| Market Cap | 4.46M USD |
| Beta (5Y Monthly) | 0.718 |
| PE Ratio (TTM) | |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CTTH Valuation Measures
| Enterprise Value | 4.47M USD |
| Trailing P/E | |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 75.99999 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -37.109 |
Trading Information
CTT Pharmaceutical Stock Price History
| Beta (5Y Monthly) | 0.718 |
| 52-Week Change | 71.17% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.1 USD |
| 52 Week Low | 0.02 USD |
| 50-Day Moving Average | 0.07 USD |
| 200-Day Moving Average | 0.07 USD |
CTTH Share Statistics
| Avg. Volume (3 month) | 26.57K USD |
| Avg. Daily Volume (10-Days) | 20.34K USD |
| Shares Outstanding | 58.66M |
| Float | 28.66M |
| Short Ratio | N/A |
| % Held by Insiders | 50.31% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -99.53% |
| Return on Equity (ttm) | -357.043% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -120338 USD |
| Net Income Avi to Common (ttm) | -155907 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 15.36K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 18.81K USD |
| Total Debt/Equity (mrq) | 34.11 USD |
| Current Ratio (mrq) | 0.495 |
| Book Value Per Share (mrq) | 0.001 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -75467 USD |
| Levered Free Cash Flow (ttm) | -90010 USD |
Profile of CTT Pharmaceutical
| Country | United States |
| State | FL |
| City | Tampa |
| Address | 3853 Northdale Blvd |
| ZIP | 33624 |
| Phone | 813-606-0060 |
| Website | https://www.cttpharmaceuticals.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1 |
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.
Q&A For CTT Pharmaceutical Stock
What is a current CTTH stock price?
CTT Pharmaceutical CTTH stock price today per share is 0.07 USD.
How to purchase CTT Pharmaceutical stock?
You can buy CTTH shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CTT Pharmaceutical?
The stock symbol or ticker of CTT Pharmaceutical is CTTH.
Which industry does the CTT Pharmaceutical company belong to?
The CTT Pharmaceutical industry is Drug Manufacturers - Specialty & Generic.
How many shares does CTT Pharmaceutical have in circulation?
The max supply of CTT Pharmaceutical shares is 58.66M.
What is CTT Pharmaceutical Price to Earnings Ratio (PE Ratio)?
CTT Pharmaceutical PE Ratio is now.
What was CTT Pharmaceutical earnings per share over the trailing 12 months (TTM)?
CTT Pharmaceutical EPS is 0 USD over the trailing 12 months.
Which sector does the CTT Pharmaceutical company belong to?
The CTT Pharmaceutical sector is Healthcare.